Evercore ISI Group Initiates Coverage On Mineralys Therapeutics with Outperform Rating

Evercore ISI Group analyst Umer Raffat initiates coverage on Mineralys Therapeutics (NASDAQ:MLYS) with a Outperform rating.

Evercore ISI Group analyst Umer Raffat initiates coverage on Mineralys Therapeutics (NASDAQ:MLYS) with a Outperform rating.

Total
0
Shares
Related Posts